Sanofi ADR (SNY) Outlook Starting To Look Brighter?

Sanofi ADR (SNY) concluded trading on Thursday at a closing price of $59.42, with 5.02 million shares of worth about $298.24 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3.29% during that period and on March 06, 2025 the price saw a gain of about 0.46%. Currently the company’s common shares owned by public are about 2.61B shares, out of which, 2.51B shares are available for trading.

Stock saw a price change of 9.75% in past 5 days and over the past one month there was a price change of 11.07%. Year-to-date (YTD), SNY shares are showing a performance of 23.20% which increased to 26.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $45.22 but also hit the highest price of $59.19 during that period. The average intraday trading volume for Sanofi ADR shares is 2.50 million. The stock is currently trading 8.27% above its 20-day simple moving average (SMA20), while that difference is up 13.75% for SMA50 and it goes to 14.40% higher than SMA200.

Sanofi ADR (NASDAQ: SNY) currently have 2.61B outstanding shares and institutions hold larger chunk of about 10.56% of that.

The stock has a current market capitalization of $148.98B and its 3Y-monthly beta is at 0.55. PE ratio of stock for trailing 12 months is 24.82, while it has posted earnings per share of $2.39 in the same period. Its PEG reads 2.20 and has Quick Ratio of 0.73 while making debt-to-equity ratio of 0.23. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNY, volatility over the week remained 1.26% while standing at 1.24% over the month.

Stock’s fiscal year EPS is expected to rise by 16.57% while it is estimated to increase by 10.97% in next year. EPS is likely to shrink at an annualized rate of 11.29% for next 5-years, compared to annual growth of 13.05% made by the stock over the past 5-years.

Coverage by Argus stated Sanofi ADR (SNY) stock as a Buy in their note to investors on July 26, 2024, suggesting a price target of $60 for the stock. Stock get a Neutral rating from JP Morgan on December 05, 2023.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.